Stelliam Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-640,000
| Closed | -$15.6M | – | 14 |
|
|
2019
Q1 | $15.6M | Buy |
640,000
+287,900
| +82% | +$7.04M | 3.24% | 7 |
|
|
2018
Q4 | $9.13M | Sell |
352,100
-165,400
| -32% | -$4.29M | 2.25% | 8 |
|
|
2018
Q3 | $16.4M | Buy |
517,500
+370,000
| +251% | +$11.7M | 0.88% | 31 |
|
|
2018
Q2 | $5.73M | Sell |
147,500
-169,500
| -53% | -$6.58M | 0.26% | 39 |
|
|
2018
Q1 | $8.75M | Buy |
+317,000
| New | +$8.75M | 0.37% | 42 |
|